BNP PARIBAS ARBITRAGE/CALL/ELI LILLY & CO/800/0.01/20.12.24 | Market Closed - Borsa Italiana 01:34:59 06/07/2024 am IST | ||
| 1.495 EUR | +3.46% |
|
| Current month | +1.36% | ||
| 1 month | +49.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 1.49 | +3.11% |
| 04/24/04 | 1.445 | +0.84% |
| 03/24/03 | 1.433 | -2.38% |
| 02/24/02 | 1.468 | -3.42% |
| 01/24/01 | 1.52 | +3.40% |
Real-time Borsa Italiana
Last update July 06, 2024 at 01:34 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| P22T98 | |
| ISIN | NLBNPIT22T98 |
| Date issued | 08/05/2024 |
| Strike | 800 $ |
| Maturity | 20/12/2024 (167 Days) |
| Parity | 100 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.615 € |
|---|---|
| Lowest since issue | 0.598 € |
| Delta | 0.78x |
| Omega | 4.399 |
| Premium | 5.19x |
| Gearing | 5.64x |
| Moneyness | 1.143 |
| Difference Strike | -114.6 $ |
| Difference Strike % | -14.32% |
| Spread | 0.06 € |
| Spread % | 3.93% |
| Theoretical value | 1.495 |
| Implied Volatility | 34.84 % |
| Total Loss Probability | 29.40 % |
| Intrinsic value | 1.057 |
| Present value | 0.4381 |
| Break even | 962.07 € |
| Theta | -0.02x |
| Vega | 0.02x |
| Rho | 0.03x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.6
USD
Average target price
870.3
USD
Spread / Average Target
-4.84%
- Stock Market
- Warrants
- P22T98 Warrant
